LeonaBio (LONA) Enterprise Value (2019 - 2026)

LeonaBio (LONA) has 8 years of Enterprise Value data on file, last reported at -$67.7 million in Q1 2026.

• Quarterly Enterprise Value fell 84.56% year-over-year to -$67.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$67.7 million (down 84.56% YoY) and the FY2025 annual result came in at -$88.3 million, down 72.27% from the prior year.
• Enterprise Value grew to -$67.7 million in Q1 2026 per LONA's latest filing, from -$88.3 million in the prior quarter.
• Across five years, Enterprise Value topped out at -$25.2 million in Q3 2025 and bottomed at -$263.5 million in Q1 2022.
• The 5-year median for Enterprise Value is -$122.1 million (2024), against an average of -$130.0 million.
• The widest annual swing landed in 2025, when Enterprise Value soared 69.96%; it then tumbled 84.56% in 2026.
• Tracing LONA's Enterprise Value over 5 years: stood at -$200.3 million in 2022, then climbed by 26.42% to -$147.4 million in 2023, then soared by 65.22% to -$51.3 million in 2024, then tumbled by 72.27% to -$88.3 million in 2025, then increased by 23.38% to -$67.7 million in 2026.
• Per Business Quant, the three latest LONA Enterprise Value figures stand at -$67.7 million (Q1 2026), -$88.3 million (Q4 2025), and -$25.2 million (Q3 2025).

Peer Comparison